$ICUI
ICU MEDICAL INC/DE Stock $icui

$icui Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000088398418000025 Filed on August 09, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue	$360.5M	$331.5M
YoY Change	8.73%	242.75%
Cost Of Revenue	$208.7M	$243.5M
YoY Change	-14.29%	422.55%
Gross Profit	$151.8M	$88.06M
YoY Change	72.38%	75.66%
Gross Profit Margin	42.11%	26.56%
Selling, General & Admin	$81.82M	$85.11M
YoY Change	-3.87%	278.4%
% of Gross Profit	53.9%	96.64%
Research & Development	$13.58M	$12.97M
YoY Change	4.69%	288.47%
% of Gross Profit	8.94%	14.72%
Depreciation & Amortization	$13.60M	$14.40M
YoY Change	-5.56%	200.0%
% of Gross Profit	8.96%	16.35%
Operating Expenses	$120.1M	$124.0M
YoY Change	-3.16%	353.16%
Operating Profit	$31.72M	-$35.93M
YoY Change	-188.28%	-257.8%
Interest Expense	$130.0K	$525.0K
YoY Change	-75.24%	993.75%
% of Operating Profit	0.41%
Other Income/Expense, Net	-$1.992M	-$2.720M
YoY Change	-26.76%	-2276.0%
Pretax Income	$29.60M	-$39.18M
YoY Change	-175.55%	-263.53%
Income Tax	-$1.457M	-$2.117M
% Of Pretax Income	-4.92%
Net Earnings	$31.05M	-$37.06M
YoY Change	-183.79%	-323.17%
Net Earnings / Revenue	8.62%	-11.18%
Basic Earnings Per Share	$1.53	-$1.87
Diluted Earnings Per Share	$1.44	-$1.87
COMMON SHARES
Basic Shares Outstanding	20.35M shares	19.82M shares
Diluted Shares Outstanding	21.57M shares	19.82M shares

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$327.2M	$240.9M
YoY Change	35.81%	-39.87%
Cash & Equivalents	$309.1M	$240.9M
Short-Term Investments	$18.07M
Other Short-Term Assets	$4.880M	$5.793M
YoY Change	-15.76%	-52.9%
Inventory	$289.0M	$401.3M
Prepaid Expenses
Receivables	$149.9M	$124.9M
Other Receivables	$110.4M	$13.40M
Total Short-Term Assets	$899.5M	$904.4M
YoY Change	-0.54%	68.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$415.7M	$374.6M
YoY Change	10.98%	369.98%
Goodwill	$13.35M	$6.652M
YoY Change	100.66%	6.52%
Intangibles	$134.8M	$160.3M
YoY Change	-15.92%	591.65%
Long-Term Investments	$5.900M
YoY Change
Other Assets	$37.38M	$29.68M
YoY Change	25.96%	57.03%
Total Long-Term Assets	$626.8M	$582.9M
YoY Change	7.54%	355.42%
TOTAL ASSETS
Total Short-Term Assets	$899.5M	$904.4M
Total Long-Term Assets	$626.8M	$582.9M
Total Assets	$1.526B	$1.487B
YoY Change	2.63%	124.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$91.19M	$40.44M
YoY Change	125.47%	114.52%
Accrued Expenses	$111.3M	$146.3M
YoY Change	-23.95%	572.44%
Deferred Revenue	$1.528M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00
YoY Change
Total Short-Term Liabilities	$202.5M	$189.1M
YoY Change	7.07%	365.61%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$75.00M
YoY Change	-100.0%
Other Long-Term Liabilities	$65.40M	$97.50M
YoY Change	-32.92%	3382.14%
Total Long-Term Liabilities	$65.40M	$75.00M
YoY Change	-12.8%	2578.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$202.5M	$189.1M
Total Long-Term Liabilities	$65.40M	$75.00M
Total Liabilities	$269.3M	$264.1M
YoY Change	1.97%	459.52%
SHAREHOLDERS EQUITY
Retained Earnings	$627.9M	$535.8M
YoY Change	17.19%	9.64%
Common Stock	$646.4M	$594.9M
YoY Change	8.66%	294.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$20.00K	$15.00K
YoY Change	33.33%	-99.66%
Treasury Stock Shares	72.00 shares	90.00 shares
Shareholders Equity	$1.257B	$1.121B
YoY Change
Total Liabilities & Shareholders Equity	$1.526B	$1.487B
YoY Change	2.63%	124.2%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	$31.05M	-$37.06M
YoY Change	-183.79%	-323.17%
Depreciation, Depletion And Amortization	$13.60M	$14.40M
YoY Change	-5.56%	200.0%
Cash From Operating Activities	$79.70M	$47.70M
YoY Change	67.09%	94.69%
INVESTING ACTIVITIES
Capital Expenditures	-$23.00M	-$12.40M
YoY Change	85.48%	129.63%
Acquisitions
YoY Change
Other Investing Activities	-$1.300M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$24.30M	-$12.40M
YoY Change	95.97%	-1650.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	9.300M	1.900M
YoY Change	389.47%	-20.83%
NET CHANGE
Cash From Operating Activities	79.70M	47.70M
Cash From Investing Activities	-24.30M	-12.40M
Cash From Financing Activities	9.300M	1.900M
Net Change In Cash	64.70M	37.20M
YoY Change	73.92%	34.3%
FREE CASH FLOW
Cash From Operating Activities	$79.70M	$47.70M
Capital Expenditures	-$23.00M	-$12.40M
Free Cash Flow	$102.7M	$60.10M
YoY Change	70.88%	101.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000883984
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	ICU MEDICAL INC/DE
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.77
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2473000	USD
CY2017Q4	icui	Accrued Product Field Action. AccruedProductFieldAction.	11810000	USD
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20467529	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018Q2	icui	Accrued Product Field Action. AccruedProductFieldAction.	8285000	USD
CY2017Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	20745000	USD
CY2018Q2	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	23706000	USD
CY2017Q4	icui	Accruedfreight Accruedfreight	5696000	USD
CY2018Q2	icui	Accruedfreight Accruedfreight	6748000	USD
CY2017Q4	icui	Accruedlegalfees Accruedlegalfees	3538000	USD
CY2018Q2	icui	Accruedlegalfees Accruedlegalfees	2425000	USD
CY2017Q4	icui	Accruedothertaxes Accruedothertaxes	2771000	USD
CY2018Q2	icui	Accruedothertaxes Accruedothertaxes	1798000	USD
	icui	Bargainpurchasegainnoncashaddback Bargainpurchasegainnoncashaddback	63237000	USD
	icui	Bargainpurchasegainnoncashaddback Bargainpurchasegainnoncashaddback	0	USD
CY2017	icui	Business Combination Consideration Transferred Equity Issued Fair Value BusinessCombinationConsiderationTransferredEquityIssuedFairValue	-413139000	USD
CY2017Q4	icui	Consignedinventory Consignedinventory	5210000	USD
CY2018Q2	icui	Consignedinventory Consignedinventory	1118000	USD
CY2017	icui	Contingentconsiderationgross Contingentconsiderationgross	225000000	USD
CY2017Q4	icui	Contractsettlement Contractsettlement	0	USD
CY2018Q2	icui	Contractsettlement Contractsettlement	2500000	USD
CY2017Q4	icui	Deferredtaxcharge Deferredtaxcharge	1326000	USD
CY2018Q2	icui	Deferredtaxcharge Deferredtaxcharge	1912000	USD
CY2017	icui	Discountonequityissuedasconsideration Discountonequityissuedasconsideration	37261000	USD
CY2017Q2	icui	Earnout Target EarnoutTarget	1000000000	USD
CY2017	icui	Fair Value Assumptions Costof Debt FairValueAssumptionsCostofDebt	0.0408
	icui	Fair Value Assumptions Costof Debt FairValueAssumptionsCostofDebt	0.0472
CY2017	icui	Fair Value Assumptions Expected Volatility Rate Adjusted Ebitda FairValueAssumptionsExpectedVolatilityRateAdjustedEBITDA	0.2600
	icui	Fair Value Assumptions Expected Volatility Rate Adjusted Ebitda FairValueAssumptionsExpectedVolatilityRateAdjustedEBITDA	0.2500
CY2017	icui	Fair Value Assumptions Market Priceof Risk FairValueAssumptionsMarketPriceofRisk	0.0599
	icui	Fair Value Assumptions Market Priceof Risk FairValueAssumptionsMarketPriceofRisk	0.0520
	icui	Fee Cap First Twelve Months FeeCapFirstTwelveMonths	62500000	USD
	icui	Fee Cap Sixmonthssubsequenttofirsttwelvemonths FeeCapSixmonthssubsequenttofirsttwelvemonths	31300000	USD
CY2017Q2	icui	Icu Medical Msa Revenue ICUMedicalMSARevenue	26300000	USD
	icui	Icu Medical Msa Revenue ICUMedicalMSARevenue	38800000	USD
CY2018Q2	icui	Icu Medical Msa Revenue ICUMedicalMSARevenue	22600000	USD
	icui	Icu Medical Msa Revenue ICUMedicalMSARevenue	39800000	USD
CY2018Q2	icui	Increase Decrease Costof Goods Sold IncreaseDecreaseCostofGoodsSold	1020000	USD
	icui	Increase Decrease Costof Goods Sold IncreaseDecreaseCostofGoodsSold	1041000	USD
CY2018Q2	icui	Increase Decrease Gross Profit IncreaseDecreaseGrossProfit	7152000	USD
	icui	Increase Decrease Gross Profit IncreaseDecreaseGrossProfit	9143000	USD
	icui	Increase Decreasein Assumed Liabilities IncreaseDecreaseinAssumedLiabilities	162786000	USD
	icui	Increase Decreasein Assumed Liabilities IncreaseDecreaseinAssumedLiabilities	0	USD
CY2018Q2	icui	Increase Decreasein Revenue IncreaseDecreaseinRevenue	-8172000	USD
	icui	Increase Decreasein Revenue IncreaseDecreaseinRevenue	-10184000	USD
	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-14185000	USD
	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-13268000	USD
CY2017Q2	icui	Legalsettlementcharge Legalsettlementcharge	0	USD
	icui	Legalsettlementcharge Legalsettlementcharge	0	USD
CY2018Q2	icui	Legalsettlementcharge Legalsettlementcharge	0	USD
	icui	Legalsettlementcharge Legalsettlementcharge	28917000	USD
CY2017Q4	icui	Liabilitiesforcontracts Liabilitiesforcontracts	40148000	USD
CY2018Q2	icui	Liabilitiesforcontracts Liabilitiesforcontracts	20468000	USD
	icui	Net Cash Paid Receivedforcurrentandprioracquisitions NetCashPaidReceivedforcurrentandprioracquisitions	157097000	USD
	icui	Net Cash Paid Receivedforcurrentandprioracquisitions NetCashPaidReceivedforcurrentandprioracquisitions	0	USD
CY2017Q4	icui	Outsidesalescommissions Outsidesalescommissions	725000	USD
CY2018Q2	icui	Outsidesalescommissions Outsidesalescommissions	1191000	USD
CY2017	icui	Paymenttoacquirebusinessnetofworkingcapitaladjustments Paymenttoacquirebusinessnetofworkingcapitaladjustments	180785000	USD
CY2017Q2	icui	Pfizer Msa Product Costs PfizerMSAProductCosts	21000000	USD
	icui	Pfizer Msa Product Costs PfizerMSAProductCosts	35700000	USD
CY2018Q2	icui	Pfizer Msa Product Costs PfizerMSAProductCosts	19500000	USD
	icui	Pfizer Msa Product Costs PfizerMSAProductCosts	37600000	USD
CY2017Q4	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	2580000	USD
CY2018Q2	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	2045000	USD
CY2017Q4	icui	Prepaidothertaxes Prepaidothertaxes	8097000	USD
CY2018Q2	icui	Prepaidothertaxes Prepaidothertaxes	5577000	USD
	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	2031000	USD
	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	513000	USD
CY2017Q2	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	19921000	USD
	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	49322000	USD
CY2018Q2	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	18690000	USD
	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	40259000	USD
CY2017Q2	icui	Strategictransactionexpenses Strategictransactionexpenses	12400000	USD
	icui	Strategictransactionexpenses Strategictransactionexpenses	33500000	USD
CY2018Q2	icui	Strategictransactionexpenses Strategictransactionexpenses	18000000	USD
	icui	Strategictransactionexpenses Strategictransactionexpenses	37800000	USD
CY2017	icui	Thirdparty Inventory ThirdpartyInventory	4284000	USD
	icui	Thirdparty Inventory ThirdpartyInventory	2014000	USD
	icui	Transitional Service Agreement Setup Costs TransitionalServiceAgreementSetupCosts	22000000	USD
CY2018Q2	icui	Treasury Stock Purchase Plan TreasuryStockPurchasePlan	40000000	USD
	invest	Investment Contract Settlement Date Range End InvestmentContractSettlementDateRangeEnd	2020-07-22
	invest	Investment Contract Settlement Date Range Start InvestmentContractSettlementDateRangeStart	2018-01-15
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	78228000	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	91186000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	112696000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	149938000	USD
CY2017Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	40682000	USD
CY2018Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	25286000	USD
CY2017Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	2104000	USD
CY2018Q2	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	1678000	USD
CY2017Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	4592000	USD
CY2018Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	4592000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	132064000	USD
CY2018Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	111280000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	13319000	USD
CY2018Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	13710000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.82
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.08
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	210139000	USD
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	236222000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14959000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17230000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	625568000	USD
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	644389000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3311000	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4444000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	144000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7300000	USD
CY2018Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8100000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	61	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1548	shares
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	269000	USD
CY2017Q4	us-gaap	Assets Assets	1496951000	USD
CY2018Q2	us-gaap	Assets Assets	1526344000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	864662000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	899542000	USD
CY2018Q2	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	24016000	USD
CY2017Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	12489000	USD
CY2017Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	12489000	USD
CY2018Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	24640000	USD
CY2018Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	24016000	USD
CY2017	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	USD
	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	USD
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	24640000	USD
CY2017Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	10061000	USD
CY2018Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	18069000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	14579000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5947000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	10061000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	18069000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	24640000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	24016000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	10061000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	18069000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	14579000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	5947000	USD
CY2017Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	14579000	USD
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017Q4	us-gaap	Business Acquisition Share Price BusinessAcquisitionSharePrice	140.75
CY2017Q4	us-gaap	Business Combination Acquired Receivables Fair Value BusinessCombinationAcquiredReceivablesFairValue	362000	USD
CY2017Q2	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	9900000	USD
CY2018Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	5947000	USD
CY2017	us-gaap	Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued	3200000	shares
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	63237000	USD
CY2018Q2	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
CY2017	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	687924000	USD
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	413139000	USD
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2017	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	450400000	USD
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	USD
CY2017Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	6000000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	6000000	USD
CY2018Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	6000000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2000000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8785000	USD
CY2017Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	19000000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	19000000	USD
CY2018Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred	7512000	USD
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred	0	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	31082000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	13911000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	12381000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	47936000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent	25080000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	131000000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	417622000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	783894000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets	29270000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	67170000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	288134000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6024000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2508000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	445082000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240923000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	290072000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	309097000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-204159000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	19025000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	300133000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	327166000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20210000	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20460000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20210000	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20460000	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	2021000	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	2046000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27204000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30688000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11570000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33658000	USD
CY2017Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	57144000	USD
CY2018Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	83788000	USD
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7099000	USD
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7100000	USD
CY2018Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7988000	USD
CY2018Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1528000	USD
CY2017Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2018Q2	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2017Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	243452000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	402246000	USD
CY2018Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	208660000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	431692000	USD
	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	6300000	USD
CY2017Q4	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	3326000	USD
CY2018Q2	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	6460000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	24775000	USD
CY2018Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	19584000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1487000	USD
CY2018Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1412000	USD
CY2017Q2	us-gaap	Depreciation Depreciation	14400000	USD
	us-gaap	Depreciation Depreciation	22600000	USD
CY2018Q2	us-gaap	Depreciation Depreciation	13600000	USD
	us-gaap	Depreciation Depreciation	27800000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29906000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	35908000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	22000	USD
CY2018Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	261000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	496000	USD
CY2017Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	98807000	USD
CY2018Q2	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	78358000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.98
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.53
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.44
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.87
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-7707000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	11200000	USD
CY2017	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0258
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0291
CY2017	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.0875
	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.0825
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	2000000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	27000000	USD
CY2018Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	29000000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	881732000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	31516000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	39692000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	58904000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	8327000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	15378000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	15517000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	15820000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	15964000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	167044000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	169602000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	135528000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	129910000	USD
CY2018Q2	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	300000	USD
CY2017Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	7361000	USD
CY2018Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	8285000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3010000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-360000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	12357000	USD
CY2018Q2	us-gaap	Goodwill Goodwill	13348000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1300000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-309000	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	1015000	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	88062000	USD
	us-gaap	Gross Profit GrossProfit	177007000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	151800000	USD
	us-gaap	Gross Profit GrossProfit	300801000	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5000000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-39177000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	6671000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	29597000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	33420000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2117000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12132000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1457000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2509000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	17459000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	70606000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	43260000	USD
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	0	USD
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-24143000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	66479000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-36387000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1999000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-66870000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12124000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	21656000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	95254000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3494000	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	4143000	USD
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1159000	shares
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1217000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1232000	shares
CY2017Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	8225000	USD
CY2018Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4902000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	175269000	USD
CY2018Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	174504000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	143753000	USD
CY2018Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	134812000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	525000	USD
	us-gaap	Interest Expense InterestExpense	1038000	USD
CY2018Q2	us-gaap	Interest Expense InterestExpense	130000	USD
	us-gaap	Interest Expense InterestExpense	265000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	163956000	USD
CY2018Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	157113000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	288657000	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	288950000	USD
CY2017Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	82397000	USD
CY2018Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	78716000	USD
CY2017Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	42304000	USD
CY2018Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	53121000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	0	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	204000	USD
CY2017Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1800000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3000000	USD
CY2018Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2900000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5700000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1496951000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1526344000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	210292000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	202466000	USD
CY2017Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	55326000	USD
CY2018Q2	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	31805000	USD
	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2022-11-08
CY2018Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	150000000	USD
CY2018Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	150000000	USD
CY2017Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	220999000	USD
CY2018Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	211648000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8531000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7067000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-186299000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39292000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28864000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	58957000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2720000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2613000	USD
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-270000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	756000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	123994000	USD
	us-gaap	Operating Expenses OperatingExpenses	229922000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	121803000	USD
	us-gaap	Operating Expenses OperatingExpenses	267872000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-35932000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-52915000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	29997000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	32929000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9017000	USD
CY2018Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14470000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	5975000	USD
CY2018Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	5631000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3135000	USD
CY2018Q2	us-gaap	Other Assets Current OtherAssetsCurrent	4880000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	38141000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	37384000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-5000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1894000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1119000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1119000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-1801000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	14000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	685000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	685000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2290000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	-569000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	4000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8888000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10914000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-17687000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	8000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	56000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9856000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	11885000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19484000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2271000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	151000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	148000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-4000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	1804000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	2167000	USD
CY2017Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4208000	USD
CY2018Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	13897000	USD
CY2017Q4	us-gaap	Other Receivables OtherReceivables	21940000	USD
CY2018Q2	us-gaap	Other Receivables OtherReceivables	431000	USD
CY2017Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	296000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	792000	USD
CY2018Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	0	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	0	USD
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	5700000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3739000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5469000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	2962000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5500000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	255800000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	157097000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1300000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2005000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4047000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8480000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27199000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47365000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	41286000	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28742000	USD
CY2017Q4	us-gaap	Prepaid Taxes PrepaidTaxes	10594000	USD
CY2018Q2	us-gaap	Prepaid Taxes PrepaidTaxes	26388000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	75000000	USD
CY2017	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	75000000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	8900000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13000000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10944000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12536000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1326000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	USD
CY2017Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3360000	USD
CY2018Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3051000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	-37060000	USD
	us-gaap	Profit Loss ProfitLoss	18803000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	31054000	USD
	us-gaap	Profit Loss ProfitLoss	35929000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	608823000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	651949000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	398684000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	415727000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1925000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	399000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-377000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12967000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24608000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13575000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26161000	USD
CY2018Q2	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	21300000	USD
	us-gaap	Restructuring Charges RestructuringCharges	2505000	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	2029000	USD
CY2018Q2	us-gaap	Restructuring Reserve RestructuringReserve	1568000	USD
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-4000	USD
CY2017Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1290000	USD
CY2018Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1018000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	585624000	USD
	us-gaap	Revenues Revenues	732493000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	627884000	USD
CY2017Q2	us-gaap	Revenues Revenues	331514000	USD
	us-gaap	Revenues Revenues	579253000	USD
CY2018Q2	us-gaap	Revenues Revenues	360460000	USD
CY2017Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	6291000	USD
CY2018Q2	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	0	USD
CY2017Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	331218000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	578461000	USD
CY2018Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	360460000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	732493000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	85106000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	149992000	USD
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	83538000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	170535000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8805000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	11759000	USD
	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	23611	shares
CY2018Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	7200000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1198254000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1257069000	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2018Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	72	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2018Q2	us-gaap	Treasury Stock Value TreasuryStockValue	20000	USD
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19821000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20312000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21569000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21536000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19821000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19153000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20352000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20304000	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued ASU No. 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The amendments in this update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. The amendments in this update also require certain disclosures about stranded tax effects. The amendments in ASU 2018-02 are effective for fiscal years beginning after December 15, 2018. Early adoption is permitted. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The amendments in this update remove the second step of the impairment test. An entity will apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit's carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The new guidance does not amend the optional qualitative assessment of goodwill impairment. The amendments in ASU 2017-04 are effective for the annual or interim impairment test in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. This ASU is not expected to have a material impact on our consolidated financial statements or related footnote disclosures.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This update amends the FASB's guidance on the impairment of financial instruments by requiring timelier recording of credit losses on loans and other financial instruments. The ASU adds an impairment model that is based on expected losses rather than incurred losses. The ASU also amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted as of the fiscal years beginning after December 15, 2018. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments in this update require an entity to recognize a right-of-use asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification as finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures.</font></div></div>

Files In Submission

Name	View Source	Status
0000883984-18-000025-index-headers.html	Edgar Link	pending
0000883984-18-000025-index.html	Edgar Link	pending
0000883984-18-000025.txt	Edgar Link	pending
0000883984-18-000025-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
icui-20180630.xml	Edgar Link	completed
icui-20180630.xsd	Edgar Link	pending
icui-20180630_cal.xml	Edgar Link	unprocessable
icui-20180630_def.xml	Edgar Link	unprocessable
icui-20180630_lab.xml	Edgar Link	unprocessable
icui-20180630_pre.xml	Edgar Link	unprocessable
icui-ex311_20180630x10q.htm	Edgar Link	pending
icui-ex312_x20180630x10q.htm	Edgar Link	pending
icui-ex321_x20180630x10q.htm	Edgar Link	pending
icui0630201810-q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICUI
ICU MEDICAL INC/DE Stock $icui

2018 Q2 Form 10-Q Financial Statement

#000088398418000025 Filed on August 09, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI ICU MEDICAL INC/DE Stock $icui

2018 Q2 Form 10-Q Financial Statement

#000088398418000025 Filed on August 09, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI
ICU MEDICAL INC/DE Stock $icui